Beste apotheek van Nederland

Mealy N E. Avanafil. Drugs of the Future 2004;29(6):628-629.
Mealy N E. Alprostadil cream. Drugs of the Future
2004;29(6):626-627.
Mealy N E, Bayes M. PT-141. Drugs of the Future
2004;29(11):1177
Mealy N E, Bayes M. ABT-724. Drugs of the Future
2005;30(9):935
Mehdiyev T V. Intracavernous injection probe of vasoactive
preparations in the diagnosis of erectile dysfunctions in patients
with diabetes mellitus. Azerbaidzhanskii Meditsinskii Zhurnal
2002;(pp 17-19):-19.
Meinhardt W, Kropman R F, Vermeij P et al. The influence of
medication on erectile function. Int J Impot Res 1997;9(1):17­
26.
Melman A, Bar-Chama N, McCullough A et al. The first human
trial for gene transfer therapy for the treatment of erectile
dysfunction: preliminary results. Eur Urol 2005;48(2):314-318.
Mendelson W B, Gujavarty K, Slintak C et al. Reported sexual
dysfunction in obstructive sleep apnea patients. Ann Clin
Psychiatry 1990;2(2):93-101.
Merrick G S, Wallner K E, Butler W M. Minimizing prostate
brachytherapy-related morbidity. Urology 2003;62(5):786-792.
Metawea B, El-Nashar A R, Gad-Allah A et al. Intracavernous
papaverine/phentolamine-induced priapism can be accurately
predicted with color Doppler ultrasonography. Urology
2005;66(4):858-860.
Meyhoff H H, Rosenkilde P, Bodker A. Non-invasive
management of impotence with transcutaneous nitroglycerin. Br
J Urol 1992;69(1):88-90.
Migliari R, Muscas G, Usai E. Effect of Casodex on sleeprelated
erections in patients with advanced prostate cancer. Br J
Urol 1992;148(2 I):338-341.
Mikhail N. Efficacy and safety of sildenafil in patients with
congestive heart failure [7]. Arch Intern Med
2004;164(18):2067-2068.
Millard R J, Stricker P D, Lynch W J et al. Risks of selfinjection
therapy for impotence. Med J Aust 1996;165(2):117­
118.
Miller D C, Wei J T, Dunn R L et al. Use of medications or
devices for erectile dysfunction among long-term prostate
cancer treatment survivors: potential influence of sexual
motivation and/or indifference. Urology 2006;68(1):166-171.
Miller N, Smolkin M E, Bissonette E et al. Undetectable
prostate specific antigen at 6-12 months: a new marker for early
success in hormonally treated patients after prostate
brachytherapy. Cancer 2005;103(12):2499-2506.
Mills R D, Sethia K K. Maximisation of the erectile
response in the investigation of impotence. Int J Impot
Res 1999;11(1):29-32.
Mills T M, Lewis R W. The role of androgens in the
erectile response: A 1999 perspective. Mol Urol
1999;3(2):75-80.
Milman H A, Arnold S B, Rivera-Miranda G et al.
Neurologic, psychological, and aggressive
disturbances with sildenafil. Ann Pharmacother
2002;36(7-8):1129-1134.
Mirone V G, Stief C G. Efficacy of apomorphine SL
in erectile dysfunction.[erratum appears in BJU Int
2002 Jan;89(1):140]. [Review] [11 refs]. BJU Int
2001;88(Suppl 3):25-29.
Mittleman M A, Glasser D B, Orazem J. Clinical trials
of sildenafil citrate (Viagra) demonstrate no increase
in risk of myocardial infarction and cardiovascular
death compared with placebo. Int J Clin Pract
2003;57(7):597-600.
Mittleman M M, Rosen R C. Evaluating clinical trial
design results and analysis of drug treatments for
erectile dysfunction. Int J Impot Res 2003;15(4):x-xiii.
Miwa Y, Kaneda T, Yokoyama O. Correlation
between the Aging Males' Symptoms Scale and sex
steroids, gonadotropins, dehydroepiandrosterone
sulfate, and growth hormone levels in ambulatory
men. Br J Sex Med 2006;3(4):723-726.
Mohr B A, Bhasin S, Link C L et al. The effect of
changes in adiposity on testosterone levels in older
men: longitudinal results from the Massachusetts Male
Aging Study. Eur J Endocrinol 2006;155(3):443-452.
Montejo A L, Llorca G, Izquierdo J A et al. Incidence
of sexual dysfunction associated with antidepressant
agents: a prospective multicenter study of 1022
outpatients. Spanish Working Group for the Study of
Psychotropic-Related Sexual Dysfunction.[see
comment]. Hillside J Clin Psychiatry 2001;62Suppl­
21.
Montejo-Gonzalez A L, Llorca G, Izquierdo J A et al.
SSRI-induced sexual dysfunction: fluoxetine,
paroxetine, sertraline, and fluvoxamine in a
prospective, multicenter, and descriptive clinical study
of 344 patients. Journal of Sex and Marital Therapy
1997;23(3):176-194.
Montorsi F. A multicenter, randomized, double-blind,
crossover study to evaluate patient preference between
tadalafil and sildenafil: Editorial comment. Eur Urol
2004;45(4):508-509.
Montorsi F, Althof S E. Partner responses to sildenafil
citrate (Viagra) treatment of erectile dysfunction.
Urology 2004;63(4):762-767.
D-143